Envoy Medical (NASDAQ:COCH) versus Lifeward (NASDAQ:LFWD) Head-To-Head Contrast

Lifeward (NASDAQ:LFWD – Get Free Report) and Envoy Medical (NASDAQ:COCH – Get Free Report) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, risk, analyst recommendations, dividends, earnings, institutional ownership and valuation.

Profitability

This table compares Lifeward and Envoy Medical’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Lifeward -155.37% -281.70% -83.03%
Envoy Medical -9,026.41% N/A -112.19%

Analyst Ratings

This is a breakdown of recent ratings for Lifeward and Envoy Medical, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Lifeward 1 1 2 0 2.25
Envoy Medical 1 1 2 0 2.25

Lifeward currently has a consensus target price of $8.00, indicating a potential upside of 97.87%. Envoy Medical has a consensus target price of $21.00, indicating a potential upside of 210.19%. Given Envoy Medical’s higher possible upside, analysts clearly believe Envoy Medical is more favorable than Lifeward.

Insider & Institutional Ownership

26.8% of Lifeward shares are owned by institutional investors. Comparatively, 8.6% of Envoy Medical shares are owned by institutional investors. 1.1% of Lifeward shares are owned by company insiders. Comparatively, 7.2% of Envoy Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Valuation and Earnings

This table compares Lifeward and Envoy Medical”s revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Lifeward $22.03 million 0.52 -$19.91 million ($16.82) -0.24
Envoy Medical $240,000.00 218.33 -$23.76 million ($4.60) -1.47

Lifeward has higher revenue and earnings than Envoy Medical. Envoy Medical is trading at a lower price-to-earnings ratio than Lifeward, indicating that it is currently the more affordable of the two stocks.

Risk and Volatility

Lifeward has a beta of 0.55, meaning that its stock price is 45% less volatile than the S&P 500. Comparatively, Envoy Medical has a beta of 2.03, meaning that its stock price is 103% more volatile than the S&P 500.

About Lifeward

(Get Free Report)

Lifeward Ltd. develops and markets medical devices for mobility, rehabilitation and physical therapy. Its products include wearable robotic exoskeletons designed to help people with mobility impairments stand and walk, as well as systems used in rehabilitation settings. The company’s offerings include the ReWalk exoskeleton for people with spinal cord injuries and the ReStore exo-suit for gait training after stroke. Lifeward also sells AlterG anti-gravity treadmills, which use differential air pressure to reduce the user’s effective body weight during walking or running exercises.

About Envoy Medical

(Get Free Report)

Envoy Medical is a medical technology company focused on developing implantable hearing devices. Based in White Bear Lake, Minnesota, the company was founded in 1995 and specializes in technologies intended to help people with hearing loss. Its product portfolio includes the Esteem Active Middle Ear Implant, an FDA-approved fully implanted hearing device for adults with moderate to severe sensorineural hearing loss. The company is also developing Acclaim, a fully implanted cochlear implant designed for people with severe to profound hearing loss.

Receive News & Ratings for Lifeward Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lifeward and related companies with MarketBeat.com's FREE daily email newsletter.